加载中
NASDAQFinancial ServicesFinancial - Conglomerates
最新数据
US$0.07
+US$0.0051 · +7.86%
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
最新数据
US$0.07
+US$0.0051 · +7.86%
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
GoAI 评分
持有
估值
85
深度低估
情绪
58
多空交织
风险
59
风险偏高
动量
25
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 |
|---|---|---|
| 销售、一般及管理费用 | 130.05万 USD | 15.17万 USD |
| 营业费用 | 130.05万 USD | 15.17万 USD |
| 利息收入 | 493.38万 USD | — |
| 营业利润 | −130.05万 USD | −15.17万 USD |
| 净利润 | 418.71万 USD | −15.17万 USD |
公司数据更新于 2026年10月12日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
